Lv4
480 积分 2023-04-09 加入
Ribociclib-Letrozole Combination as an Alternative for Neoadjuvant Chemotherapy in Selected Postmenopausal Patients with Luminal Breast Cancer (BOOG 2017-01)
1个月前
已完结
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial
1个月前
已完结
Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
1个月前
已完结
Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial
1个月前
已完结
Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation
1个月前
已完结
The role of addiction insufficiency in reading problems
3个月前
已关闭
Efficacy and safety of subcutaneous mosunetuzumab in combination with lenalidomide and as a monotherapy in Japanese patients with relapsed/refractory follicular lymphoma
3个月前
已完结
原发性腹膜后软组织肉瘤诊治
8个月前
已完结
皖公网安备34019202002308
